Physician profile
Herbert Lazarus
NPI 1730288416
$2,858.32
in general payments reported to CMS, 2019-2025
26 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $330 · 2021: $430 · 2022: $284 · 2023: $539 · 2024: $348 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $853.18 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Abbvie INC. | $526.56 | 2019-2025 | |
| Sanofi Pasteur INC. | $223.77 | 2019-2025 | |
| Kaleo, INC. | $195.43 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $147.95 | 2019-2025 | |
| Genentech USA, INC. | $111.26 | 2019-2022 | |
| Seqirus USA INC | $75.33 | 2021-2023 | Flucelvax Quadrivalent |
| Ironshore Pharmaceuticals INC. | $73.64 | 2019-2020 | |
| Amgen INC. | $72.51 | 2019-2021 | |
| Antares Pharma, INC. | $70.14 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $62.69 | 2020-2023 | Crysvita |
| Takeda Pharmaceuticals U.S.A., INC. | $61.71 | 2021 | |
| Hologic Sales and Service, LLC | $42.79 | 2025 | Aptima |
| Alk-Abello, INC | $42.00 | 2023 | Grastek, Odactra, Ragwitek |
| Merck Sharp & Dohme LLC | $41.47 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $39.10 | 2019-2021 | |
| Phadia US INC. | $36.27 | 2020-2024 | Immunocap |
| Collegium Pharmaceutical, INC. | $35.70 | 2025 | Jornay Pm |
| Corium, LLC | $26.29 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.94 | 2019 | |
| Welch Allyn | $19.60 | 2021 | |
| Cranial Technologies, INC | $18.48 | 2019 | |
| Sobi, INC | $17.96 | 2019 | |
| Medexus Pharma, INC. | $14.93 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.55 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Lazarus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.